Topical antibiotic monotherapy means using an antibiotic gel or lotion by itself, without benzoyl peroxide or a retinoid, for acne. For adults with persistent acne, solo use is not recommended, and long-term adult-only comparisons are still missing. Persistent acne means breakouts that continue from the teen years into adulthood. Resistance risk drives current practice, and combination care is the expected path.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Why solo antibiotics are not recommended
- What doctors prescribe instead
- How strong is the resistance concern
- What is still missing for adults
Why solo antibiotics are not recommended
The American Academy of Dermatology's 2024 acne guidelines do not recommend topical antibiotics including erythromycin, clindamycin and minocycline as monotherapy because of bacterial resistance risk, as reported by MDedge in MDedge summary of the guidelines. The concern is bacteria learning to survive the drug.
When that happens, red bumps return faster and the same gel helps less. That is why doctors avoid refills of solo antibiotic gels for months.
What doctors prescribe instead
The same guidelines strongly recommend fixed-dose combinations of topical antibiotic with benzoyl peroxide and/or retinoid, with concomitant benzoyl peroxide to suppress resistance development, according to Clinical Advisor in Clinical Advisor summary of the guidelines. Benzoyl peroxide lowers the chance that resistant bacteria take over.
Ask your dermatologist how the parts fit your skin. Common patterns to discuss include: Use exactly as directed and report burning, bleaching, or no change. Do not layer an old antibiotic gel on top.
- antibiotic plus benzoyl peroxide together, not antibiotic alone
- added retinoid when clogged pores need maintenance care
- clear stop date and follow-up plan
How strong is the resistance concern
A 2025 systematic review of 23 studies with 2,046 Cutibacterium acnes isolates found resistance of 22.38% to clindamycin and 29.20% to erythromycin, with macrolide resistance up to 48%, reported by Frontiers in Microbiology in Frontiers in Microbiology review. The numbers come from lab isolates, not from one clinic.
For an adult who needs care for months, that risk matters. It explains why short solo courses rarely solve persistent breakouts.
What is still missing for adults
Current recommendations are extrapolated from general acne trials with few adult-persistent-acne-only randomized trials and uncertain optimal duration, so researchers still lack long-term monotherapy versus combination outcomes in adults, as noted by BMJ Open in BMJ Open review protocol. Adult care still borrows from teen and mixed-age studies.
Keep a simple log of products, dates, irritation, and flares. Bring past antibiotic use and benzoyl peroxide response to the visit. Ask when to stop, switch, or step down to maintenance.
You Might Also Like
- The 2026 Review of Topical Antibiotic Monotherapy for Acne: A Source-Checked 2026 Briefing for Adults With Persistent Acne
- Spironolactone, Metformin, and Bicalutamide for Acne in a 2026 Review: What Researchers Still Need to Learn for Adults With Persistent Acne
- Oral Doxycycline for Acne in a 2026 Systematic Review: A Source-Checked 2026 Briefing for Adults With Persistent Acne